Sofosbuvir/Daclatsavir/Ribavirin for 12 Weeks in Patients with Genotype 3 Hepatitis C and Advanced Fibrosis/Cirrhosis: Results from a Real World Cohort
JOURNAL OF HEPATOLOGY(2016)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
JOURNAL OF HEPATOLOGY(2016)